National Health Investors (NYSE:NHI) Stock Price Down 5.2% – Here’s What Happened

Shares of National Health Investors, Inc. (NYSE:NHI) were down 5.2% during trading on Tuesday . The stock traded as low as $69.91 and last traded at $70.2830. 35,506 shares traded hands during mid-day trading, a decline of 92% from the average daily volume of 433,820 shares. The stock had previously closed at $74.15.

Key Stories Impacting National Health Investors

Here are the key news stories impacting National Health Investors this week:

• Positive Sentiment: NHI reported second-quarter revenue of $121.32 million, up 1.6% year over year and well above the approximately $72.12 million analyst estimate. Reported EPS of $1.19 also exceeded the $0.84 consensus estimate. NHI Announces Second Quarter 2026 Results
• Positive Sentiment: The healthcare REIT declared a quarterly dividend of $0.92 per share, equivalent to $3.68 annually and a reported yield of approximately 5%. The dividend is payable November 6 to shareholders of record September 30. This supports NHI’s income-oriented investment appeal.
• Neutral Sentiment: NHI issued an investor update and supplemental second-quarter portfolio information, giving investors additional detail on its healthcare real estate portfolio and operating performance. NHI Issues Investor Update
• Negative Sentiment: Second-quarter FFO, a key REIT profitability measure, was $1.19 per share, below the $1.26 consensus estimate and down from $1.22 a year earlier. The miss is likely weighing more heavily on investors than the GAAP EPS beat. National Health Investors Q2 FFO Lag Estimates
• Negative Sentiment: Management’s updated FY 2026 EPS guidance of $4.74–$4.79 is below the approximately $4.87 analyst consensus, signaling weaker-than-expected earnings expectations for the year.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on the stock. Truist Financial lowered their target price on shares of National Health Investors from $89.00 to $81.00 and set a “buy” rating on the stock in a report on Friday, June 12th. Weiss Ratings cut shares of National Health Investors from a “buy (b)” rating to a “buy (b-)” rating in a research note on Friday, June 12th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $94.00 price target on shares of National Health Investors in a report on Wednesday, April 22nd. Wells Fargo & Company reduced their price target on shares of National Health Investors from $84.00 to $79.00 and set an “equal weight” rating on the stock in a research report on Monday, June 1st. Finally, BMO Capital Markets dropped their target price on shares of National Health Investors from $90.00 to $80.00 and set an “outperform” rating for the company in a research note on Monday, June 15th. Five equities research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $83.86.

National Health Investors Trading Down 5.4%

The stock has a market capitalization of $3.40 billion, a price-to-earnings ratio of 22.63, a PEG ratio of 3.38 and a beta of 0.51. The company has a debt-to-equity ratio of 0.83, a current ratio of 8.20 and a quick ratio of 8.20. The business has a 50 day simple moving average of $75.18 and a 200-day simple moving average of $79.56.

National Health Investors Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 6th. Investors of record on Wednesday, September 30th will be issued a dividend of $0.92 per share. This represents a $3.68 dividend on an annualized basis and a dividend yield of 5.2%. The ex-dividend date is Wednesday, September 30th. National Health Investors’s dividend payout ratio (DPR) is presently 118.71%.

Insider Buying and Selling at National Health Investors

In related news, Director Robert A. Mccabe, Jr. bought 890 shares of National Health Investors stock in a transaction that occurred on Monday, June 15th. The stock was purchased at an average cost of $71.65 per share, with a total value of $63,768.50. Following the purchase, the director owned 44,159 shares in the company, valued at approximately $3,163,992.35. This trade represents a 2.06% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO D. Eric Mendelsohn bought 1,500 shares of the stock in a transaction on Friday, June 5th. The shares were purchased at an average price of $68.84 per share, with a total value of $103,260.00. Following the acquisition, the chief executive officer owned 133,316 shares in the company, valued at approximately $9,177,473.44. This represents a 1.14% increase in their position. The SEC filing for this purchase provides additional information. Insiders own 2.70% of the company’s stock.

Institutional Investors Weigh In On National Health Investors

Hedge funds and other institutional investors have recently bought and sold shares of the company. Principal Financial Group Inc. raised its holdings in shares of National Health Investors by 1.9% in the fourth quarter. Principal Financial Group Inc. now owns 1,668,006 shares of the real estate investment trust’s stock valued at $127,386,000 after purchasing an additional 30,968 shares during the last quarter. Forty three Eighteen Advisors LLC bought a new position in National Health Investors in the first quarter valued at $2,005,000. M&T Bank Corp acquired a new stake in National Health Investors in the 4th quarter valued at $2,996,000. Legal & General Group Plc increased its stake in National Health Investors by 22.8% in the 4th quarter. Legal & General Group Plc now owns 251,588 shares of the real estate investment trust’s stock valued at $19,214,000 after buying an additional 46,715 shares during the last quarter. Finally, Morgan Stanley Institutional Investment Advisors LLC bought a new stake in National Health Investors during the 4th quarter worth about $5,883,000. Institutional investors and hedge funds own 62.51% of the company’s stock.

About National Health Investors

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.